Global Food Grade Urolithin B Market Strategic Research Report
By Type: Purity: >98%, Purity: >99%, Others
By Application: Food, Beverage
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: Suzhou Myland Pharm & Nutrition Inc., Carlo Sessa SpA, Shandong Longilat Biotechnology Co., Ltd, Cofttek, BINBO BIOLOGICAL CO., LTD, Xi'an Jincuifang Plant Technology Development Co., Ltd., Nanjing Bencao Yikang Biotechnology Co., Ltd., Hubei Wanzhi Chemical Pharmaceutical Co., Ltd., Zhejiang Hengtengfu Pharmaceutical Co., Ltd., Xi'an Tianguangyuan Biotechnology Co., Ltd., Wuhan Dongkangyuan Technology Co., Ltd., Sichuan Wekeqi Biotechnology Co., Ltd.
개요
Scope of the Report
The global Food Grade Urolithin B market size is predicted to grow from US$ 12.48 million in 2025 to US$ 18.89 million in 2032; it is expected to grow at a CAGR of 6.2% from 2026 to 2032.
Urolithin B is a new bioactive compound, which is a linoleic acid compound produced by intestinal flora metabolism. Urolithin B has strong antioxidant capacity, can delay aging, improve health, and can effectively regulate physiological functions in the human body, protect cardiovascular health, and reduce the possibility of tumor occurrence.
Global key Food Grade Urolithin B players cover Suzhou Myland Pharm & Nutrition Inc., Carlo Sessa SpA, Shandong Longilat Biotechnology Co., Ltd, Cofttek, BINBO BIOLOGICAL CO.,LTD, etc.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Food Grade Urolithin B market?
What factors are driving Food Grade Urolithin B market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Food Grade Urolithin B market opportunities vary by end market size?
How does Food Grade Urolithin B break out by Type, by Application?
This report presents a comprehensive overview of the global Food Grade Urolithin B market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- Purity: >98%
- Purity: >99%
- Others
Segment by Application
- Food
- Beverage
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Food Grade Urolithin B market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Food, Beverage evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Food Grade Urolithin B Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 Purity: >98%
- 3.1.3 Purity: >99%
- 3.1.4 Others
- 3.1.5 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Food
- 4.1.3 Beverage
- 4.1.4 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 Suzhou Myland Pharm & Nutrition Inc.
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 Carlo Sessa SpA
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 Shandong Longilat Biotechnology Co., Ltd
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Cofttek
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 BINBO BIOLOGICAL CO.,LTD
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 Xi'an Jincuifang Plant Technology Development Co., Ltd.
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 Nanjing Bencao Yikang Biotechnology Co., Ltd.
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 Hubei Wanzhi Chemical Pharmaceutical Co., Ltd.
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
- 8.9 Zhejiang Hengtengfu Pharmaceutical Co., Ltd.
- 8.9.1 Company Overview
- 8.9.2 Key Products & Segments
- 8.9.3 Financial Performance (2023–2025)
- 8.9.4 Business Strategy
- 8.9.5 SWOT Analysis
- 8.9.6 Strategic Implications (2026–2032)
- 8.10 Xi'an Tianguangyuan Biotechnology Co., Ltd.
- 8.10.1 Company Overview
- 8.10.2 Key Products & Segments
- 8.10.3 Financial Performance (2023–2025)
- 8.10.4 Business Strategy
- 8.10.5 SWOT Analysis
- 8.10.6 Strategic Implications (2026–2032)
- 8.11 Wuhan Dongkangyuan Technology Co., Ltd.
- 8.11.1 Company Overview
- 8.11.2 Key Products & Segments
- 8.11.3 Financial Performance (2023–2025)
- 8.11.4 Business Strategy
- 8.11.5 SWOT Analysis
- 8.11.6 Strategic Implications (2026–2032)
- 8.12 Sichuan Wekeqi Biotechnology Co., Ltd.
- 8.12.1 Company Overview
- 8.12.2 Key Products & Segments
- 8.12.3 Financial Performance (2023–2025)
- 8.12.4 Business Strategy
- 8.12.5 SWOT Analysis
- 8.12.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
How big is the global Food Grade Urolithin B market?
How fast is the Food Grade Urolithin B market expected to grow?
What does the Food Grade Urolithin B market cover?
What are the main segments of the Food Grade Urolithin B market by type?
Which applications drive demand in the Food Grade Urolithin B market?
Who are the key players in the Food Grade Urolithin B market?
Which regions and countries are covered for Food Grade Urolithin B?
What is driving growth in the Food Grade Urolithin B market?
Who should buy the Food Grade Urolithin B market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Related reports
Navadhi Market Research · Food & BeveragesGlobal Infant Formula Human Milk Oligosaccharides Market Strategic Research Report
The global infant formula Market Strategic Research Report">global infant formula human milk oligosaccharides (HMO) market has emerged as one of the most scientif…
Navadhi Market Research · Food & BeveragesGlobal Automated Commercial Kitchen Robotics Market Strategic Research Report
The global automated commercial kitchen robotics market is undergoing a decisive structural shift as food service operators confront a persistent labor shortage, mou…
Navadhi Market Research · Food & BeveragesGlobal Direct To Consumer Coffee Subscription Market Strategic Research Report
The global direct-to-consumer (DTC) coffee subscription market has emerged as one of the most commercially compelling intersections of specialty food culture, recurr…
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Food Grade Urolithin B Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Leading Brands in This Industry
